HEADER VIRAL PROTEIN/IMMUNE SYSTEM 11-MAY-22 7XRP TITLE CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH NANOBODY TITLE 2 C5G2 (LOCALIZED REFINEMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NTD; COMPND 5 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: C5G2 NANOBODY; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: SPIKE PROTEIN S1; COMPND 13 CHAIN: F; COMPND 14 FRAGMENT: RBD; COMPND 15 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: S, 2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: CAMELUS DROMEDARIUS; SOURCE 10 ORGANISM_TAXID: 9838; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 15 2; SOURCE 16 ORGANISM_TAXID: 2697049; SOURCE 17 GENE: S, 2; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, NEUTRALIZING NANOBODY, CRYO-EM, VIRAL PROTEIN, VIRAL KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR L.LIU,H.SUN,Y.JIANG,X.LIU,D.ZHAO,Q.ZHENG,S.LI,N.XIA REVDAT 2 16-OCT-24 7XRP 1 REMARK REVDAT 1 05-OCT-22 7XRP 0 JRNL AUTH D.ZHAO,L.LIU,X.LIU,J.ZHANG,Y.YIN,L.LUAN,D.JIANG,X.YANG,L.LI, JRNL AUTH 2 H.XIONG,D.XING,Q.ZHENG,N.XIA,Y.TAO,S.LI,H.HUANG JRNL TITL A POTENT SYNTHETIC NANOBODY WITH BROAD-SPECTRUM ACTIVITY JRNL TITL 2 NEUTRALIZES SARS-COV-2 VIRUS AND THE OMICRON VARIANT BA.1 JRNL TITL 3 THROUGH A UNIQUE BINDING MODE. JRNL REF J NANOBIOTECHNOLOGY V. 20 411 2022 JRNL REFN ISSN 1477-3155 JRNL PMID 36109732 JRNL DOI 10.1186/S12951-022-01619-Y REMARK 2 REMARK 2 RESOLUTION. 3.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.880 REMARK 3 NUMBER OF PARTICLES : 120400 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7XRP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1300029233. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYO-EM STRUCTURE OF SARS-COV-2 REMARK 245 SPIKE PROTEIN IN COMPLEX WITH REMARK 245 NANOBODY C5G2 (LOCAL REFINEMENT) REMARK 245 ; SARS-COV-2 SPIKE PROTEIN; REMARK 245 NANOBODY C5G2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TECNAI F30 REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 67 REMARK 465 ILE A 68 REMARK 465 HIS A 69 REMARK 465 VAL A 70 REMARK 465 SER A 71 REMARK 465 GLY A 72 REMARK 465 THR A 73 REMARK 465 ASN A 74 REMARK 465 GLY A 75 REMARK 465 THR A 76 REMARK 465 LYS A 77 REMARK 465 ARG A 78 REMARK 465 GLU A 96 REMARK 465 LYS A 97 REMARK 465 SER A 98 REMARK 465 PHE A 133 REMARK 465 GLN A 134 REMARK 465 PHE A 135 REMARK 465 CYS A 136 REMARK 465 ASN A 137 REMARK 465 ASP A 138 REMARK 465 PRO A 139 REMARK 465 PHE A 140 REMARK 465 LEU A 141 REMARK 465 GLY A 142 REMARK 465 VAL A 143 REMARK 465 TYR A 144 REMARK 465 TYR A 145 REMARK 465 HIS A 146 REMARK 465 LYS A 147 REMARK 465 ASN A 148 REMARK 465 ASN A 149 REMARK 465 LYS A 150 REMARK 465 SER A 151 REMARK 465 TRP A 152 REMARK 465 MET A 153 REMARK 465 GLU A 154 REMARK 465 SER A 155 REMARK 465 GLU A 156 REMARK 465 PHE A 157 REMARK 465 ARG A 158 REMARK 465 VAL A 159 REMARK 465 TYR A 160 REMARK 465 SER A 161 REMARK 465 SER A 162 REMARK 465 ALA A 163 REMARK 465 ASN A 164 REMARK 465 MET A 177 REMARK 465 ASP A 178 REMARK 465 LEU A 179 REMARK 465 GLU A 180 REMARK 465 GLY A 181 REMARK 465 LYS A 182 REMARK 465 GLN A 183 REMARK 465 GLY A 184 REMARK 465 ASN A 185 REMARK 465 PHE A 186 REMARK 465 LEU A 244 REMARK 465 HIS A 245 REMARK 465 ARG A 246 REMARK 465 SER A 247 REMARK 465 TYR A 248 REMARK 465 LEU A 249 REMARK 465 THR A 250 REMARK 465 PRO A 251 REMARK 465 GLY A 252 REMARK 465 ASP A 253 REMARK 465 SER A 254 REMARK 465 SER A 255 REMARK 465 SER A 256 REMARK 465 GLY A 257 REMARK 465 TRP A 258 REMARK 465 THR A 259 REMARK 465 ALA A 260 REMARK 465 ASP B 1 REMARK 465 PRO F 330 REMARK 465 ASN F 331 REMARK 465 ILE F 332 REMARK 465 THR F 333 REMARK 465 ASN F 334 REMARK 465 LEU F 335 REMARK 465 LEU F 518 REMARK 465 HIS F 519 REMARK 465 ALA F 520 REMARK 465 PRO F 521 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 214 N - CA - C ANGL. DEV. = -26.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 33 17.64 -142.80 REMARK 500 ASP A 88 41.45 39.99 REMARK 500 THR A 109 -2.62 -140.35 REMARK 500 ASN A 121 55.06 -97.30 REMARK 500 HIS A 207 46.49 -140.95 REMARK 500 ASN A 211 -67.28 -104.86 REMARK 500 LEU A 226 -62.36 -90.42 REMARK 500 ALA A 292 14.39 -143.36 REMARK 500 LEU A 293 -60.38 -95.83 REMARK 500 SER B 29 -36.89 -130.24 REMARK 500 THR B 107 -60.04 -92.98 REMARK 500 PHE F 342 -64.22 -90.28 REMARK 500 TYR F 369 -9.75 72.38 REMARK 500 ASP F 405 47.43 -85.67 REMARK 500 CYS F 488 140.29 -170.86 REMARK 500 ARG F 509 91.94 -69.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS F 336 PRO F 337 -148.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-33416 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH REMARK 900 NANOBODY C5G2 (LOCAL REFINEMENT) DBREF 7XRP A 27 309 UNP P0DTC2 SPIKE_SARS2 27 309 DBREF 7XRP B 1 125 PDB 7XRP 7XRP 1 125 DBREF 7XRP F 330 521 UNP P0DTC2 SPIKE_SARS2 330 521 SEQRES 1 A 283 ALA TYR THR ASN SER PHE THR ARG GLY VAL TYR TYR PRO SEQRES 2 A 283 ASP LYS VAL PHE ARG SER SER VAL LEU HIS SER THR GLN SEQRES 3 A 283 ASP LEU PHE LEU PRO PHE PHE SER ASN VAL THR TRP PHE SEQRES 4 A 283 HIS ALA ILE HIS VAL SER GLY THR ASN GLY THR LYS ARG SEQRES 5 A 283 PHE ASP ASN PRO VAL LEU PRO PHE ASN ASP GLY VAL TYR SEQRES 6 A 283 PHE ALA SER THR GLU LYS SER ASN ILE ILE ARG GLY TRP SEQRES 7 A 283 ILE PHE GLY THR THR LEU ASP SER LYS THR GLN SER LEU SEQRES 8 A 283 LEU ILE VAL ASN ASN ALA THR ASN VAL VAL ILE LYS VAL SEQRES 9 A 283 CYS GLU PHE GLN PHE CYS ASN ASP PRO PHE LEU GLY VAL SEQRES 10 A 283 TYR TYR HIS LYS ASN ASN LYS SER TRP MET GLU SER GLU SEQRES 11 A 283 PHE ARG VAL TYR SER SER ALA ASN ASN CYS THR PHE GLU SEQRES 12 A 283 TYR VAL SER GLN PRO PHE LEU MET ASP LEU GLU GLY LYS SEQRES 13 A 283 GLN GLY ASN PHE LYS ASN LEU ARG GLU PHE VAL PHE LYS SEQRES 14 A 283 ASN ILE ASP GLY TYR PHE LYS ILE TYR SER LYS HIS THR SEQRES 15 A 283 PRO ILE ASN LEU VAL ARG ASP LEU PRO GLN GLY PHE SER SEQRES 16 A 283 ALA LEU GLU PRO LEU VAL ASP LEU PRO ILE GLY ILE ASN SEQRES 17 A 283 ILE THR ARG PHE GLN THR LEU LEU ALA LEU HIS ARG SER SEQRES 18 A 283 TYR LEU THR PRO GLY ASP SER SER SER GLY TRP THR ALA SEQRES 19 A 283 GLY ALA ALA ALA TYR TYR VAL GLY TYR LEU GLN PRO ARG SEQRES 20 A 283 THR PHE LEU LEU LYS TYR ASN GLU ASN GLY THR ILE THR SEQRES 21 A 283 ASP ALA VAL ASP CYS ALA LEU ASP PRO LEU SER GLU THR SEQRES 22 A 283 LYS CYS THR LEU LYS SER PHE THR VAL GLU SEQRES 1 B 125 ASP VAL GLN LEU VAL GLU SER GLY GLY GLY SER VAL GLN SEQRES 2 B 125 ALA GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 B 125 LYS PHE SER HIS LEU VAL PHE LEU GLY TRP PHE ARG GLN SEQRES 4 B 125 ALA PRO GLY LYS GLU ARG GLU GLY VAL ALA ALA GLY LEU SEQRES 5 B 125 GLY ALA TYR GLU SER GLY TYR TYR ALA ASP SER VAL LYS SEQRES 6 B 125 GLY ARG PHE THR VAL SER LEU ASP ASN ALA GLU ASN THR SEQRES 7 B 125 VAL TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR SEQRES 8 B 125 ALA LEU TYR TYR CYS ALA ALA LEU VAL VAL LEU SER ARG SEQRES 9 B 125 ASP ASN THR GLU PHE ILE ALA HIS ASN TYR TRP GLY GLN SEQRES 10 B 125 GLY THR GLN VAL THR VAL SER SER SEQRES 1 F 192 PRO ASN ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE SEQRES 2 F 192 ASN ALA THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG SEQRES 3 F 192 LYS ARG ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU SEQRES 4 F 192 TYR ASN SER ALA SER PHE SER THR PHE LYS CYS TYR GLY SEQRES 5 F 192 VAL SER PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN SEQRES 6 F 192 VAL TYR ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL SEQRES 7 F 192 ARG GLN ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP SEQRES 8 F 192 TYR ASN TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL SEQRES 9 F 192 ILE ALA TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY SEQRES 10 F 192 GLY ASN TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER SEQRES 11 F 192 ASN LEU LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE SEQRES 12 F 192 TYR GLN ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY SEQRES 13 F 192 PHE ASN CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN SEQRES 14 F 192 PRO THR ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL SEQRES 15 F 192 VAL LEU SER PHE GLU LEU LEU HIS ALA PRO HET NAG A 401 14 HET NAG A 402 14 HET NAG A 403 14 HET NAG F 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 4(C8 H15 N O6) HELIX 1 AA1 ASP B 62 LYS B 65 5 4 HELIX 2 AA2 LYS B 87 THR B 91 5 5 HELIX 3 AA3 PHE F 338 ASN F 343 1 6 HELIX 4 AA4 ARG F 403 ILE F 410 5 8 HELIX 5 AA5 GLY F 502 GLN F 506 5 5 SHEET 1 AA1 7 TYR A 28 SER A 31 0 SHEET 2 AA1 7 SER A 60 TRP A 64 -1 O VAL A 62 N THR A 29 SHEET 3 AA1 7 TYR A 266 TYR A 269 -1 O VAL A 267 N THR A 63 SHEET 4 AA1 7 VAL A 90 SER A 94 -1 N TYR A 91 O GLY A 268 SHEET 5 AA1 7 ASN A 188 ILE A 197 -1 O PHE A 192 N PHE A 92 SHEET 6 AA1 7 TYR A 200 PRO A 209 -1 O LYS A 202 N LYS A 195 SHEET 7 AA1 7 GLU A 224 LEU A 229 -1 O LEU A 229 N PHE A 201 SHEET 1 AA2 3 LEU A 48 PHE A 55 0 SHEET 2 AA2 3 GLN A 271 TYR A 279 -1 O GLN A 271 N PHE A 55 SHEET 3 AA2 3 ILE A 285 ASP A 290 -1 O ASP A 287 N LYS A 278 SHEET 1 AA3 6 LEU A 84 PRO A 85 0 SHEET 2 AA3 6 ARG A 237 LEU A 241 -1 O PHE A 238 N LEU A 84 SHEET 3 AA3 6 GLY A 103 GLY A 107 -1 N ILE A 105 O GLN A 239 SHEET 4 AA3 6 LEU A 117 VAL A 120 -1 O LEU A 117 N PHE A 106 SHEET 5 AA3 6 VAL A 126 LYS A 129 -1 O LYS A 129 N LEU A 118 SHEET 6 AA3 6 GLU A 169 SER A 172 -1 O TYR A 170 N ILE A 128 SHEET 1 AA4 4 LEU B 4 GLU B 6 0 SHEET 2 AA4 4 ARG B 19 ALA B 24 -1 O ALA B 23 N VAL B 5 SHEET 3 AA4 4 THR B 78 GLN B 82 -1 O LEU B 81 N LEU B 20 SHEET 4 AA4 4 THR B 69 ASP B 73 -1 N ASP B 73 O THR B 78 SHEET 1 AA5 5 GLY B 10 GLN B 13 0 SHEET 2 AA5 5 THR B 119 SER B 124 1 O GLN B 120 N GLY B 10 SHEET 3 AA5 5 ALA B 92 LEU B 99 -1 N TYR B 94 O THR B 119 SHEET 4 AA5 5 VAL B 32 GLN B 39 -1 N PHE B 37 O TYR B 95 SHEET 5 AA5 5 ARG B 45 GLU B 46 -1 O GLU B 46 N ARG B 38 SHEET 1 AA6 4 GLY B 10 GLN B 13 0 SHEET 2 AA6 4 THR B 119 SER B 124 1 O GLN B 120 N GLY B 10 SHEET 3 AA6 4 ALA B 92 LEU B 99 -1 N TYR B 94 O THR B 119 SHEET 4 AA6 4 TYR B 114 TRP B 115 -1 O TYR B 114 N ALA B 98 SHEET 1 AA7 2 ALA B 49 ALA B 50 0 SHEET 2 AA7 2 TYR B 59 TYR B 60 -1 O TYR B 59 N ALA B 50 SHEET 1 AA8 5 ASN F 354 ARG F 357 0 SHEET 2 AA8 5 THR F 393 SER F 399 -1 O SER F 399 N ASN F 354 SHEET 3 AA8 5 VAL F 510 GLU F 516 -1 O SER F 514 N TYR F 396 SHEET 4 AA8 5 GLY F 431 ALA F 435 -1 N CYS F 432 O LEU F 513 SHEET 5 AA8 5 PHE F 377 TYR F 380 -1 N TYR F 380 O GLY F 431 SHEET 1 AA9 2 LEU F 452 ARG F 454 0 SHEET 2 AA9 2 LEU F 492 SER F 494 -1 O GLN F 493 N TYR F 453 SSBOND 1 CYS A 131 CYS A 166 1555 1555 2.03 SSBOND 2 CYS A 291 CYS A 301 1555 1555 2.03 SSBOND 3 CYS B 22 CYS B 96 1555 1555 2.04 SSBOND 4 CYS F 336 CYS F 361 1555 1555 2.04 SSBOND 5 CYS F 379 CYS F 432 1555 1555 2.06 LINK ND2 ASN A 122 C1 NAG A 403 1555 1555 1.44 LINK ND2 ASN A 165 C1 NAG A 401 1555 1555 1.44 LINK ND2 ASN A 282 C1 NAG A 402 1555 1555 1.44 LINK ND2 ASN F 343 C1 NAG F 601 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000